Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

AVITA Medical (RCEL) Accumulated Depreciation & Amortization (2019 - 2025)

AVITA Medical filings provide 7 years of Accumulated Depreciation & Amortization readings, the most recent being -$8.0 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 11.47% to -$8.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$8.0 million, a 11.47% increase, with the full-year FY2025 number at -$8.0 million, up 11.47% from a year prior.
  • Accumulated Depreciation & Amortization hit -$8.0 million in Q4 2025 for AVITA Medical, up from -$9.1 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $540000.0 in Q1 2021 to a low of -$9.1 million in Q4 2024.
  • Median Accumulated Depreciation & Amortization over the past 5 years was -$836000.0 (2022), compared with a mean of -$1.8 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: surged 111.76% in 2021 and later plummeted 760.78% in 2024.
  • AVITA Medical's Accumulated Depreciation & Amortization stood at -$696000.0 in 2021, then decreased by 9.34% to -$761000.0 in 2022, then plummeted by 38.37% to -$1.1 million in 2023, then tumbled by 760.78% to -$9.1 million in 2024, then grew by 11.47% to -$8.0 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were -$8.0 million (Q4 2025), -$9.1 million (Q4 2024), and -$1.1 million (Q4 2023) per Business Quant data.